FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

1,048 letters match. Newest first.

  1. Northern VA Compounders PLLC, dba Akina Pharmacy

    FDA warns Akina Pharmacy over unsafe production of compounded drugs and sterility risks.

    High risk
  2. Royal Philips

    FDA warns Royal Philips over unvalidated supplier molding for CT monitor cable and unreported device corrections at Suzhou plant.

    High risk
  3. La Sucursal Produce Inc.

    La Sucursal Produce lacked FSVP for imported husk tomato, green onion, and peas and failed to register its Los Angeles facility.

    Medium
  4. Euro USA Inc

    Euro USA Inc’s seafood HACCP plans had inadequate temperature limits, monitoring, and corrective actions.

    High risk
  5. Appleton City Feed Service LLC

    FDA warned Appleton City Feed Service, a Missouri medicated feed mill, of pest, cross-contamination and drug-combination risks in animal feed.

    High risk
  6. New India Bazar, Inc.

    FDA cites New India Bazar for missing FSVP and allergen hazard analysis after MAGGI noodle recall.

    High risk
  7. Thuan Thien Producing Trading Limited Company

    FDA warns Thuan Thien that its frozen juices lack validated 5-log pathogen reduction and coconut juice treatment is inadequate.

    High risk
  8. Beckman Coulter Inc.

    FDA warns Beckman Coulter over inadequate quality-system procedures for DxI 9000 immunoassay devices.

    High risk
  9. Zoet Poultry, Inc.

    Zoet Poultry's shell egg farm lacked an implemented Salmonella Enteritidis prevention plan and required environmental testing.

    High risk
  10. Dermal Source, Inc.

    FDA warned Dermal Source that five topical anesthetic products are unapproved and misbranded drugs with lidocaine above OTC limits.

    High risk
  11. SeeNext Venture, Ltd.

    FDA warns SeeNext Venture over unapproved, misbranded NumbSkin lidocaine creams sold online.

    High risk
  12. TKTX Company

    TKTX Company sells unapproved, misbranded lidocaine numbing creams online at illegal concentrations for cosmetic procedures.

    High risk
  13. Higley Industries, Inc.

    FDA warns Higley Industries over CGMP failures in OTC drug manufacturing, including untested ethanol and glycerin.

    High risk
  14. ReNovo, Inc. DBA Provision Device Reprocessing Solutions

    ReNovo, a device reprocessor in Bend, Oregon, sold new device models without required FDA clearances and had quality system failures.

    High risk
  15. Sol-Millennium Medical, Inc.

    Sol-Millennium marketed modified syringes and needles without required FDA clearance and had quality-system and reporting violations.

    High risk
  16. Sen Up Huat Seafood Trading Sdn Bhd

    FDA warns Malaysian seafood processor Sen Up Huat over inadequate histamine controls in its seafood safety plan for bonito and other fish.

    High risk
  17. Human Microbes

    FDA warned Human Microbes that selling fecal microbiota for transplantation as an unapproved drug and unlicensed biologic lacks required BLA or IND.

    High risk
  18. Nobles Medical Technology II, Inc.

    FDA warns Nobles Medical Technology II over oversight failures in NobleStitch EL clinical study.

    High risk
  19. Exactech, Inc.

    Exactech shoulder and hip implants had quality-system and medical-device reporting failures, including a late GXL liner wear report.

    High risk
  20. Native Salts LLC

    FDA warns Native Salts LLC over unapproved, misbranded ammonia smelling-salt stimulant sold as 'N, Native Salts'.

    High risk
  21. Dream Wholesale, Inc

    Dream Wholesale, an importer of frozen spinach and chickpeas, lacked required Foreign Supplier Verification Program (FSVP) checks.

    High risk
  22. Bell International Laboratories, Inc.

    Bell International Laboratories, an OTC drugmaker, was cited for manufacturing rule violations including missing glycerin DEG/EG testing and inadequate quality oversight.

    High risk
  23. Barsotti Juice Company, Inc.

    FDA warned Barsotti Juice that its organic carrot juice safety plan does not control Clostridium botulinum.

    High risk
  24. Agila Corporation dba Woody’s Pet Food Deli

    FDA found Salmonella and Listeria in Woody's raw pet food and an unapproved additive in use.

    High risk
  25. Fresenius Kabi AG

    FDA warned Fresenius Kabi about quality and reporting failures for its Ivenix Infusion System.

    High risk
  26. Trang Thuy Seafood Co., LTD

    FDA found Trang Thuy Seafood's tuna HACCP plan did not control histamine formation after a histamine poisoning recall.

    High risk
  27. Gilster-Mary Lee Corporation

    Gilster-Mary Lee's recalled HyVee skillet meal was misbranded because its label did not declare milk, a major allergen.

    High risk
  28. Healthtex Distributors, Inc.

    FDA found Healthtex Distributors' dietary supplements adulterated for CGMP failures and misbranded for labeling violations.

    Medium
  29. Pt Dua Kelinci

    FDA found Pt Dua Kelinci made ready-to-eat snacks under insanitary conditions, with dirty equipment and allergen cross-contact risks.

    High risk
  30. Synthetix Inc. DBA Helix Chemical Supply

    FDA says Synthetix Inc., doing business as Helix Chemical Supply, sold unapproved and misbranded Semaglutide and Tirzepatide drugs online.

    High risk
  31. Madhu Instruments Private Limited

    FDA cites Madhu Instruments in New Delhi for insanitary conditions in sterile drug manufacturing and places it on import alert.

    High risk
  32. Barkey GmbH & Co. KG

    FDA warns Barkey over unapproved plasmatherm V blood thawing device and missing design risk analysis.

    High risk
  33. QuVa Pharma, Inc.

    FDA warned QuVa Pharma, a sterile drug outsourcing facility in Bloomsbury, NJ, of mold in its cleanest filling area and other CGMP failures.

    High risk
  34. Curtis Jacquot dba Pacific BioLogic Co.

    Pacific BioLogic's dietary supplements had manufacturing violations and disease claims making them unapproved drugs.

    High risk
  35. Iowa Egg Company Inc.

    Iowa Egg Company Inc. shell egg farm cited for Salmonella Enteritidis prevention, temperature, pest, testing and record violations.

    High risk
  36. Indian Groceries and Spices, Inc.

    FDA says Indian Groceries and Spices lacked required foreign supplier checks for imported cumin, chili powder, and mung beans.

    Medium
  37. Perfection Bakeries Inc., dba Aunt Millie’s Bakeries

    Perfection Bakeries, dba Aunt Millie’s, recalled Our Family white hot dog buns because the label did not declare sesame.

    High risk
  38. Ehy Holdings, LLC

    FDA warned Ehy Holdings over unupdated drug listings for nicotine patches and creams, calling products misbranded.

    Low
  39. Les Importations Herbasanté Inc.

    Canadian contract maker of homeopathic drugs, including children's products, skipped ingredient testing and process validation, FDA says.

    High risk
  40. Inmar Supply Chain Solutions, LLC

    FDA found severe rodent infestation at Inmar warehouse, adulterating stored foods, over-the-counter drugs, and devices.

    High risk
  41. S & J International Enterprises Public Company Limited

    FDA cited S & J International Enterprises for CGMP violations, data integrity failures, and limiting access to records during a drug inspection.

    High risk
  42. Grace Supply Inc.

    Grace Supply lacked required foreign supplier verification for most imported foods and adequate Salmonella verification for shredded coconut.

    High risk
  43. JJR Global Inc.

    FDA warns JJR Global over missing FSVP for imported chutneys and other foods.

    Medium
  44. Martin Farm, Konrad Martin

    Nappanee dairy farm used enrofloxacin and ceftiofur in calves contrary to labeling and kept incomplete treatment records.

    High risk
  45. ReConserve Inc.

    FDA warned ReConserve Inc. that animal-food ingredients stored outdoors uncovered were contaminated and its preventive controls were inadequate.

    High risk
  46. Dr. Joel Kaplan Inc.

    FDA warned Dr. Joel Kaplan Inc. that its sexual health devices are unapproved, misbranded, and made under quality system violations.

    High risk
  47. Samuel Rodriguez dba KiloKennelzz

    KiloKennelzz marketed Green Monster, an unapproved injectable animal drug, online with claims to treat dog diseases.

    High risk
  48. MiMedx Group, Inc.

    FDA cites MiMedx for marketing placental product AXIOFILL without BLA or IND and for CGMP failures.

    High risk
  49. Jeffrey W. Taub, M.D./Children's Hospital of Michigan

    FDA warns Detroit investigator over pediatric drug trial protocol deviations and lapsed IRB approval.

    High risk
  50. Deymed Diagnostic s.r.o.

    Deymed Diagnostic s.r.o.'s BrainFeedback Pro, TruScan LT, and DuoMAG NL devices had quality system violations in design, complaints, production, and records.

    Medium